Cytek Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | -69.5% | -364.2% | – | +380.6% | -118.5% | |
| – | +95.1% | +106.0% | +355.6% | +63.1% | +13.7% | +14.2% | |
| – | +127.1% | +977.9% | +152.0% | +32.9% | +21.8% | -8.4% | |
| – | +66.0% | +164.2% | +145.3% | – | – | – | |
| – | -750.8% | – | – | – | – | -162.2% | |
| – | +59.0% | +182.1% | +126.1% | -51.1% | -27.0% | +15.9% | |
| – | +59.0% | +1,257.0% | +166.3% | +67.9% | -11.6% | – | |
| – | – | – | – | +602.4% | – | – | |
| – | – | – | -100.1% | +21,024.9% | -51.1% | -30.2% | |
| – | +0.0% | -200.0% | – | -119.3% | – | -76.9% | |
| – | +131,735.5% | +74.2% | -97.4% | -858.4% | -62.2% | -15.1% | |
| – | – | +46.4% | -132.8% | – | – | – | |
| – | – | -98.0% | -8,407.9% | – | +4,713.7% | -140.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.